620.80
-2.30%
Axis Direct
We expect gross margins to be impacted due to an increase in revenue share from the non-regulated market going onwards, therefore recommend HOLD' with a target price of Rs 1,670/share (PE 20x for FY23EPS).
Promoters unpledged 6.10% of shares in last quarter. Total pledge stands at 34.64% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended